Expanded Access Program for Melphalan Flufenamide (Melflufen) in Triple Class Refractory Multiple Myeloma
Clinical trial NCT04534322 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04534322
- Sponsor
- Oncopeptides AB
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.